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1'his 36-month prospective study of a group of 61 people at 
high .risk to develop multiple basal cell carcinomas (BCe) 
eXamllled the circulating lymphocyte subsets of the popula-
tlon, patterns of sun exposure, and the longitudinal develop-
ment of basal cell carcinoma. Sun exposure status was highly 
forrelated with immune status defined by the CD 4/ CDs T-
Ymphocyte ratio. There were significantly more BCC at 18 fnd 36 months in the 35 patients with high sun exposure and 
Ow CD4/CDs ratio than in the 20 patients with low sun 
exposure and high CD4/CDs ratio. 
A multivariate analysis assessed the relative importance of 
prior basal cell carcinoma, sun exposure, and immune status 
on the development of the skin cancer. Basal cell carcinoma 
developing in the previous 18 months and sun exposure dur-
ing those 18 months were the first and second most impor-
tant variables in determining development of basal cell carci-
noma during the next 18 months. CD4/CDs ratio had no 
additional predictive ability once prior skin cancers and sun 
exposure were accounted for. A low ratio of CD4/CDs cells 
correlated with high sun exposure during the preceding 18 
months.] Invest DermatoI99:227 -231 , 1992 
--------------------------------------------------------------------------------------------------------
A berrant local immune responses may relate to the ini-tiation of tumor production in patients with multiple basal cell carcinomas (BCC). Support for this hypoth-esis comes from the decreased reactivity to dinitro-chlorobenzene and intradermally injected antigens in 
shn-exposed skin [1] and the T heiperlTsuppressor (T HITs) ratio of 
t e tumor infiltrate was lower than the ratio in circulating cells 
Suggesting impaired recruitment ofT-helper cells [2]. The exten-
~\Te work of Kripke demonstrated that mice pretreated with small 
oses of UVB light lose the capacity to reject UVB-induced skin 
tumors [3]. 
B EXtensive human studies of the lymphocytic infiltrate around 
. Cc exist but there are a limited number of studies of the systemic 
Immunologic status of those having BCe. Usually these studies 
Involve analysis oflymphocyte subsets during the preoperative eval-
Uation of exceedingly large and aggressive tumors [4,5-10J. The 
~esults of such studies in patients with BCC are conflicting. Dellon 
oUnd small BCC to be associated with a high T -cell level but large 
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l\bbreviation~: 
BCC: basal cell carcinoma 
NK.: natural killer 
SCC: squamons cell carcinoma 
SPF: Sun protection factor 
1'1i: l' helper 
1's: 1'suppressor 
UVR: ultraviolet radiation 
squamous cell carcinoma (SCC) to be associated with low T-cell 
levels. Fourteen patients with multiple BCC had decreased bl as to-
genic responses to Con A, a qualitative defect, in peripheral blood 
lymphocytes [6,7]. In contrast, Weimer et al [11] found normal T-
and B-lymphocyte levels in 50 patients with basal and squamous cell 
skin cancer. May et al [9] also found T and B lymphocytes to be 
within normal ranges in the pre-operative evaluation of a group of 
patients having BCC and SCC; however, the mean percentage of 
T -helper cells was decreased with a lower helper Isuppressor ratio in 
BCC and SCC patients. 
The hypothesis that directed this study was that the development 
of BCC in a susceptible population is related to genetic factors and 
to measurable parameters: al te-rations in the ratio ofT HITs lympho-
cytes in peripheral blood, past and current attempts to decrease sun 
exposure, and past and current development of BCC. It also ad-
dressed the possible usefulness of low-dose systemic retinoids on 
development of BCC in high-risk patients. 
MATERIALS AND METHODS 
Subjects and Study Design Sixty-one patients from 50 to 68 
years of age with two or more biopsy-proved basal cell carcinomas 
less than 2 cm in diameter in the previous five years were enrolled 
consecutively in the study. These biopsies were performed by a 
number of physicians who did not participate in the study but did 
send pathologic specimens for review. Subjects with either Fitzpa-
trick type I or II skin having extensive and clinically equivalent 
actinic damage were recruited for this study at the time of their 
routine examination 6 months following a skin cancer removal. 
None of these subjects traveled to sunny climates in winter months. 
These patients had no malignancy of other organs, psoriasis, atopic 
dermatitis, or autoimmune disease at the time of entry into the study 
or during the subsequent year. None had a history of viral infection, 
sunburn, or deliberate tanning or skin surgery within the 2 weeks 
prior to the time blood samples were taken. No individuals were 
0022-202X/92/S05 .00 Copyright © 1992 by The Society for Investigative Dermatology, Inc. 
227 
228 ROBINSON AND RADEMAKER 
Table I. Sun-Exposure Index' 
Question 
1. Prior to developing 
your first skin cancer, 
did you use a sunscreen? 
2. Describe your current 
use of sunscreens: 
3. Describe your habit of 
outdoor activities since 
the time of your sur-
gery: 
4. Have your habits 
changed since your 
surgery so that you 
now limit outdoor ac-
tivity? 
Response 
Yes 
Sometimes 
No 
> 15 rating all year 
> 15 rating in summer only 
< 15 rating all year 
< 15 rating in summer only 
Not using sunscreen 
No outdoor activities 
All activities between 10 
and 3 and no sunbathing 
Deliberate sunbathing 
Yes 
No 
Contribution 
to Index 
o 
t 
1 
o 
t 
t 
l 
1 
o 
t 
1 
o 
1 
• Index, sum of four response components. Minimum possible, 0; low-sun exposure 
index < 1.5. Maximum possible, 4; high-sun exposure index> 2.75. 
taking medication known to act as an immunosuppressive. No pa-
tients had basal cell nevus syndrome. 
Blood and skin biopsies were obtained at four visits: baseline and 
6, 12, and 18 months and skin biopsies were done at 36 months. At 
each visit, after the blood was obtained, each subject had a total body 
skin examination by one of us (JKR). All clinically suspicious le-
sions were biopsied and surgically removed. Only those specimens 
interpreted by the pathologist as basal cell carcinoma were recorded. 
In order to be classified as a new skin cancer, the site of the biopsy 
was different from the site that was previously treated. Thus, each· 
subsequent skin cancer was determined to be a new one and not a 
recurring one. 
At the time of entry into the study, all subjects were given written 
recommendations for sun protection that consisted of information 
about minimizing sun exposure during the hours between 10:00 
A.M. and 2:00 P.M.; wearing a hat and long-sleeved shirts when out 
in the sun; and applying a sunscreen with a sun protection factor 
(SPF) of 15 or greater before every exposure to the sun. Subjects 
were given sequential numbers at the time of entry. 
All subjects completed a written mail-in survey questionnaire at 
the conclusion of the study. This questionnaire was numbered with 
the subject'S study number and subjects were assured that their iden-
tity was unknown to the physician. The questionnaire elicited in-
formation about the individual's habits of deliberate tanning behav-
ior, outdoor activities, use of protective clothing and sunscreens 
before developing a skin cancer and after receiving the educational 
information given in association with this study (Table 1). 
After the baseline blood and skin evaluation, subjects were ran-
domized in a double-blinded manner into two groups of those re-
ceiving 10 mg of isotretinoin daily and those receiving placebo. 
Subjects and the investigator were informed which group they were 
in after completing 3 years of taking the medication or placebo. 
Lymphocyte Subpopulations in Blood Mononuclear cells 
were separated from fresh heparinized blood samples by Ficoll-
Hypaque density gradient centrifugation. Lymphocyte cell subpop-
ulations were quantitated using direct conjugated monoclonal anti-
bodies labeled with either FITC (Leu 5, 18, 2, and B\) or 
phycoerythrin (HLA-DR, Leu 3, and 11) (Becton-Dickinson, 
Mountain View, CA). These monoclonal antibody combinations 
used were: Leu 5-FITC/HLA-DR-PE, Leu 18-FITC/Leu 3-PE, 
Leu 2-FITC/Leu Il-PE, and B\-FITC/Leu M3-PE. T helper (T H) 
cells and T suppressor (Ts) cells were recognized by Leu 3 or CD4 
and by Leu-2 or CD8. Appropriate mouse immunoglobulin direct 
conjugated negative controls for red and green immunofluores-
cence were used. The total lymphocyte count per mm of blood was 
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determined for each sample with a complete blood count and differ-
ential of white blood cells. 
Flow-cytometric analysis of the lymphocytes was performe.d 
with a Coulter EPICS C flow cytometer by four parameter analYSIS 
of individual cells for forward angle and log ninety degree angle 
light scatter to identify the lymphocyte population and log red an.d 
log green fluorescence to identify staining by the monoclonal anti-
bodies. 
Statistical Methods Longitudinal data (BCC development, ratio 
of CD4/CDB cells, and sun exposure) were compared between 
treatment groups using a nested repeated measures analysis of yard 
iance [13]. Exposure was correlated with CD4/CDB cell ratios an 
treatment (all dichotomized) using the Fisher exact test [12]. Bee 
development (prior 5 years, 1-18 months, 19-36 months) was 
compared across the three subgroups defined by exposure statu.S and 
CD4/CDB ratio using nested repeated measures analysis of vanance 
[13]. This analysis (which was statistically significant) was follow: d 
by pair-wise t tests at a given time. For the t tests, adjustment lOr 
unequal variance was made if necessary [12]. Stepwise multiple re-
gression analysis was used to determine the relative importance of 
prior BCC, sun exposure, and CD4/CDB ratio on development 0 
BCC from 1 to 18 months and from 19 to 36 months [14]. Numberd 
ofBCC from 1 to 18 months and 19 to 36 months were correlate 
using the Pearson correlation coefficient and accompanying t test 
for zero correlation [12]. All criteria for statistical significance were 
p < 0.05. 
RESULTS 
All patients had normal numbers of total lymphocytes, natural killer 
cells, and B cells. The treatment groups (isotretinoin, placebo) were 
not significantly different on prior basal cell carcinoma (BCe) or 
BCC development at 18 months and at 36 months. Also, there was 
no difference between treatment groups in mean T H, T s, and T tl/is 
ratio for the four assessment points (baseline and 6, 12, and 
months). Therefore, treatment was excluded as a correlate in further 
analyses. d 
Each patient had four evaluation points (baseline and 6, 12, an 
18 months) for the CD4/CDB ratio. This ratio ranged from 0.85 to 
13.25 with a mean of3.06 (SD = 1.84). The patient population w~ 
subdivided into two groups. The low CD4/CDs ratio group ~on 
sisted of 41 patients in whom the T H/Ts ratio wasless than 3.0 In ~t 
least three of four evaluations. In 38 of these patients the mean ratl~ 
was less than 3.2, whereas in three the mean ratio was between 3:U 
and 4.0. In 30 patients, the T H/Ts ratio was less than 3.0 at a 0 
evaluation points. The high CD4/CDs ratio group consists of 2 f 
patients in ~hom .the ratio was .greater t.han 3.0 on at least twO O2 four evaluation pomts. Mean ratios for thiS group were all above 3. 
(Fig 1). 
The sun-exposure index is an indication of a patient's approach to 
sun exposure since surgery and of previous use of sunscreen. BecauJ; 
surgery occurred 5 years prior to entering the study and the s~ 
continued for 36 months, this represents 8 years of sun prot~ctd~~ 
for some of those with low exposure. The sun-exposure 111 . h 
ranged from 1.00 (lowest exposure) to 4.00 (highest expos,:re) wit 0 
a mean of 2.6 (SD = 1.3). The index classified patients 111tO tw e 
distinct groups. Twenty-six patients were in the low-exposu:
n groul?, having an index of 1:5 or l~ss.Thirty-five patients ~ere ~n 
the high-exposure group havmg an mdex of 2. 7 5 or more (Fig 2)~n_ 
contrast to the 'high-exposure group, the low-exposure group c 1-
sisted of individuals who changed their sunscreen habits since deve r 
oping cancer, who tended to use a sunscreen with a protection factO 
of 15 or more, and who limited their outdoor activities. '0 
Sun-exposure index was highly correlated with CD4/CDB ra~1 h 
In the low-exposure group, 77% (20 of 26) of patients had ~~gh 
CD4/CDB ratios, whereas none of high-exposure patients had Igof 
CD4/CDs ratios (p < 0.0001). Table II gives the mean number of 
BCC in the 5 years prior to starting the study, the mean num
d
ber 1-
BCC developed from 1 to 18 months, and the new number eV~Jl 
oped from 19 to 36 months for the three subgroups defined by s 
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~gure 1. Scatter plot offour evaluation points for the CD4/CDs ratio for the 61 subjects. Solid squares, high CD4/CDs ratio; ope" squares, low CD4/CDs ratio. 
Ote: subject 56 had a CD4/CDa value of 19.7, which is not plotted because it distorts the presentation of the rest of the data. 
~l(posure and immune status. There was a significantly higher inci-
e~ce of BCC development at all three time periods in the 35 
patients with high sun exposure and low CD4/CDs ratio compared 
WI:h the 20 patients with low sun exposure and high CD4/CDs fatlo. Low CD 4/ CDs ratio without high sun exposure did not corre-
ate with increased prior or prospective BCC development. 
. A multivariate analysis was used to assess the relative statistical 
~ltlportance of numbers of prior BCC, sun exposure, and CD4/CDs 
atlo on the development of BCC from 1 to 18 months and from 19 
fio 36 months . Numbers of prior BCC and sun exposure were the 
rst (p < 0.0001) and second (p = 0.02) most important variables, 
respectively. CD4/CDs ratio had no additional predictive ability 
?nce prior BCC and sun exposure were accounted for. The order of 
IhPurtance and the strength of the relationships remained un-
~ anged when the dichotomous variables of sun exposure and 
wPh4/CDs ratio were replaced with actual sun exposure index or 
t 111 person mean T H/Ts ratio. 
. Basal cell carcinoma development from 19 to 36 months was 
Sl 'fi gnl cantly correlated with BCC development from 1 to 18 
~onths (correlation coefficient = 0.94, P < 0.001) . The numbers 
~ls BCC 'present in the 5 years prior to starting the study was 
o significantly correlated with BCC developed from 1 to 18 ;~nths; however, this correlation (correlation coefficient == 0.87, 
d 0.0001) was not as strong as the one between numbers ofBCC 
yeveloPing from 1 to 18 months and from 19 to 36 months. In the 5 
o?rs p~ior to entering the study, subjects were treated by a number 
t physI.clans employing differing criteria for biopsy oflesions prior 
bO entenng the study. Subjects may have had BCC treated without a 
StlOpsy, thus making this correlation somewhat weaker. The 
a r~nb~th of this study was 36 months of uniform clinical inspection 
n 10psy of all suspicious lesions. 
DISCUSSION 
Two b . . I ' d C h ' gr aSlC Immuno oglc erense mec al1lsms may prevent tumor 
ie O~th and progression: natural killer (NK) cells and T cells . Stud-
s t at examine the infiltrate around tumors indicate that the T -
cell- mediated immune response modulates tumor growth 
[2,5 ,15-17]. Helper T cells are known to playa central role in 
mediating the activity of NK cells. By producing interferon and 
interleukin-2, helper T cells stimulate NK cell cytotoxicity [18-
20] that plays a crucial role in tumor rejection. Others have shown 
that abnormal NK cell activity is present in BCC and squamous cell 
carcinoma [16,21] and malignant melanoma [22,23]. Thus, the 
correlation of elevated CD4/CDs ratio with decreased numbers of 
BCC formed during this study may be a result of better immune 
surveillance of early BCC in some patients. In previous studies 
retinoids stimulated interleukin 2 production by T-helper cells in 
mice with resultant T killer cell proliferation [24] . In this study, 
there was no evidence of such an effect in humans because low-dose 
systemic retinoid did not inhibit the production of new BCe. * 
In animals, systemic effects attributed to multiple exposures to 
UV radiation (UVR) were lessened response to antigens and in-
creased tolerance to transplanted UV induced skin tumors [3,25] . 
Futhermore, this UV radiation-induced susceptibility to tumor 
growth was explained in the mouse by a set of suppressor T cells, 
which arose in UVR-treated animals and functioned to prevent 
immunologic rejection of the tumor [25 - 28]. Although the immu-
nologic consequences of UVR in mice are known, studies in 
humans are beginning to suggest similar consequences. In mice, 
low-dose UVB radiation impaired the induction of contact hyper-
sensitivity if the allergen was applied to irradiated skin [29]. Local-
ized, low-dose UVB in humans impaired the induction of contact 
hypersensitivity to DNCB in 40% of normal controls and in 92% of 
skin cancer patients [30] . A standard course of UVB or UVA in a 
commercial tanning apparatus was found to induce a decreased T 
helper: T suppressor cell ratio and increased suppressor activity of 
peripheral blood T lymphocytes to pokeweed mitogen-stimulated 
* Tangrea JA, Edwards BK, Taylor PR, et al: Long-term therapy with 
low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter 
clinical trial. J Nat! Cancer Inst 84:328 - 332, 1992. 
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Figure 2. Sun-exposure index of the 61 subjects. Lines, high sun-exposure index > 2.75 and low sun-exposure index < 1.5. Solid squares, high sun_exposure 
index; opetl squares, low sun-exposure index. 
immunoglobulin production [31]. UVR inducing a reduction of 
natural-killer cell activity was found up to 14 d after cessation of 
UVR in irradiated subjects but not in controls [31-33]. 
This prospective study examined the circulating T-cell subsets of 
a population that voluntarily practiced various types of sun protec-
tion and the rate of development of new skin cancers. The aim of 
this study was not toassess immediate changes in lymphocytes based 
upon a single UVR exposure that produces erythema, but rather to 
assess one marker of the immunologic status of people with moder-
ate daily sun exposure. Once entered into the study, the individuals 
stratified into two groups in their patterns of sun protection, which 
was estimated by the sun-exposure index. Persons with high sun 
exposure exhibited low CD4/CD8 ratios. This finding of the study 
Table II. Basal Cell Carcinoma Development by Group 
Determined by Sun Exposure and Immune Status 
Sun CD4/CDB 
Group Exposure Ratio Prior' 
Low" Low/NV 2.7 ± 0.3 
(n = 6) 
2 Highb Low/NL 3.5 ± O.4g 
(n = 35) 
3 Low HighJ 2.5 ± 0.1 
(n = 20) 
, Sun exposure index < 1.5. 
• Sun exposure index> 2.75. 
' T HITs < 3.0 in three of four evaluations. 
J T HITs> 3.0 in two of four evaluations. 
Bcd (mean ± SEM) 
18 M 36M 
0.3 ± 0.3 2.2 ± 1.4 
3.0 ± 0.7g 5.5 ± 1.3g 
0.2 ± 0.1 1.1 ± 0.3 
, Prior, number of BCC in individual patient in the 5 years preceding the study. 
fN umberofBCC in individual patient in 18 months or in 19- to 36-month period of 
the study. 
, Significantly different from group 3 in same column. 
was made possible because study subjects chose to continue un~ro' 
tected sun exposure despite recommendations about sun protectionS 
Thus, this study suggests that human sun exposure over at least 1. 
months had an immunologic effect in this group of subjects suscepd' 
ble to BCC development. Perhaps adequate sun protection can mO • 
ify the suspected immunologic effect of UVR. Certainly this ared 
requires further investigation. Those who had low sun exposure an 
also had an elevated CD4/CD8 ratio formed significantly fewer 
BCC during the course of the study. However, the single bes( 
indicator of the development of future BCC was the number.o 
BCC in the prior 18 months. Other studies have defined an In' 
creased risk of developing BCC for those with one or more prior 
BCC [34-39]. The differences between these reported risks maa 
reflect the number ofBCC prior to entering the study, the metho 
used to determine that number, and the intensity of sun protection 
practiced by the population during the course of the study. 
This study examined patients already identified as susceptible to 
developing BCe. In this group, the number of prior skin canc~& 
and sun exposure index (a rough measure of attempts to modi c' 
normal patterns of sun exposure) best correlated with the prospe • 
tive development of new BCC. This suggests that BCC develo~ 
ment is an innate characteristic modified by sun exposure. In thiS 
high-risk population, sun exposure correlated with persistent abnod' 
mali ties in T H/Ts ratio. If the variable of sun exposure was remove ~ 
the T H/Ts ratio was not correlated with increased BCC develoP 
ment. 
One possible interpretation of this finding is that maximal suscePd 
tibility to UVR-induced BCC and susceptibility to UVR-induce • 
decreased T H/T s ratio are determined by the same genetic characc 
teristics. Individuals susceptible to UVR-induced immunolog~ 
changes may also be those susceptible to UVR-induced skin cance ~ 
as suggested by Yoshikawa et al [30] . TH/Ts ratio may be o~c 
UVR-sensitive function, but it is not necessarily the immunolog:t 
function responsible for UVR-induced skin cancer. It could be t 
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UVR-induction of skin cancer and UVR-induced immunologic 
changes are genetically coordinate, determined by the same charac-
tens tICS such as UVR release of tumor necrosis factor alpha as sug-
gested by Streilein and colleagues [40] or UVR-induced damage of 
the p53 gene, which normally operates as a growth suppressor [41]. 
However, the immunologic changes may not themselves be neces-
sary for the development and persistence of BCe. Indeed in this 
study, the CD4/CDs ratio had no predictive value once prior skin 
cancer and sun exposure were accounted for. This does not exclude 
the real and likely possibility that the number of BCC that devel-
oped previously were dependent on a genetic susceptibility to 
UVR-induced changes of which immunologic suppressor is a com-
ponent. 
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